evidencegaps
Primary study · included by 1 review

Neoadjuvant Nivolumab Therapy for Esophageal Squamous Cell Carcinoma: A Single-Arm, Phase II Study.

Park 2024 · Park Sehhoon, Lee Yurimi, Lee Jiyun, et al. · Cancer research and treatment · 2024

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Park 2024 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.